doxazosin has been researched along with Bladder Diseases in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yono, M | 1 |
Yoshida, M | 1 |
Yamamoto, Y | 1 |
Imanishi, A | 1 |
Fukagawa, A | 1 |
Latifpour, J | 1 |
Eto, M | 1 |
Meier, AH | 1 |
van Waalwijk van Doorn, ES | 1 |
Delaere, KP | 1 |
2 other studies available for doxazosin and Bladder Diseases
Article | Year |
---|---|
Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Doxazosin; Gene Expression; Gene Expression | 2010 |
A 3-month double-blind study of doxazosin as treatment for benign prostate bladder outlet obstruction.
Topics: Doxazosin; Humans; Male; Prostatic Diseases; Randomized Controlled Trials as Topic; Urinary Bladder | 1995 |